References
- Arrang J. M., Garbarg M., Quach T. T., Tuong M. T., Yeramian E., Schwartz J. C. Actions of betahistine at histamine receptors in the brain. Eur J Pharmacol 1985; 111: 73–84
- Martinez D. M. The effect of Sere (betahistine hydrochloride) on the circulation of the inner ear in experimental animals. Acta Otolaryngol 1972; 305: 28
- Unemoto H., Sasa M., Takaori S., Ito J., Matsuoka I. Inhibitory effect of betahistine on polysynaptic neurons in the lateral vestibular nucleus. Arch Otorhinolaryngol 1982; 236: 229–36
- Ell J., Gresty M. The effects of the « vestibular sedative » drug flunarizine upon the vestibular and oculomotor systems. J Neurol Neurosurg Psychiatry 1983; 46: 716–24
- Legent F., Calais C., Cellier D. Vertiges paroxystiques iteratifs et Sere® : étude clinique controlée. Concours Médical 1988; 110 (29): 2539–43
- Conraux C., Cellier D. Les sensations vertigineuses chroniques : essai comparatif Sere® 8 mg versus placebo, double aveugle, randomisé, multicentrique chez des patients souffrant de sensations vertigineuses chroniques. Impact Médecin 1988; 260: 63–5
- Etbaz P., Haguenauer J. P., Muler H., Portmann M. Activité thérapeutique d'un inhibiteur de la surcharge calcique. la flunarizine, dans les troubles vestibulaires : étude en double insu contre placebo. J Fr ORL 1986; 35: 301–8
- Elbaz P. Flunarizine and betahistine : two different therapeutic approaches in vertigo compared in a double-blind study. Acta Otolaryngol 1988; 460 (suppl): 143–8